Eli Lilly Files 6 Lawsuits Over Illegal Retatrutide Sales, Reporting 14,000 Listings in 100 Countries
Updated
Updated · Yahoo Finance · Aug 12
Eli Lilly Files 6 Lawsuits Over Illegal Retatrutide Sales, Reporting 14,000 Listings in 100 Countries
3 articles · Updated · Yahoo Finance · Aug 12
Summary
Six new lawsuits target U.S. compounding pharmacies, medical spas and online sellers that Lilly says are illegally marketing black-market retatrutide to consumers.
Retatrutide remains in Phase 3 trials and has not been approved anywhere, which Lilly and the FDA say makes consumer sales illegal and potentially dangerous.
More than 200 individuals and entities have been referred by Lilly to the FDA, Justice Department, state attorneys general, law enforcement and licensing boards as the company widens its crackdown.
Over 14,000 websites, ads, social posts and product listings in more than 100 countries have already been reported by Lilly, which is also pressing payment firms, platforms and shippers to cut off sellers.
Will Eli Lilly's global crackdown dismantle the underground peptide market, or simply drive unregulated foreign imports deeper into the shadows?
With unprecedented weight loss promised, are consumers risking their lives on contaminated black-market injections before the anticipated 2027 FDA approval?